Target Global

  • DATABASE (360)

  • ARTICLES (712)

    • DATABASE (360)
    • ARTICLES (712)
  • Sort by
    • Relevance
    • Date

Greycroft is a New York-based VC, established in 2006, that currently has 113 companies in its portfolio. It has interests in multiple sectors but a preference for A.I. and Big Data technologies underpinning them.  It has managed 35 exits to date including Farfetch and Huffington Post. Its recent investments include in the US$60m Series C financing round of multilingual AI-driven translation platform Unbabel and in the US$22m Series A round of Kheiron, a breast cancer-detecting health tech. 

Launched in 2018, Everbright New Economy USD Fund (New Economy Fund) is under the umbrella of China Everbright, a Hong Kong-listed financial conglomerate. The New Economy Fund started from an inaugural fund of US$483m, with US$150m from Bahrain-based asset manager Investcorp. It invests mainly in the e-commerce, smart retail and artificial intelligence sectors. In November 2019, China Everbright and Investcorp announced they will co-manage Investcorp New Economy Fund I and explore the opportunity to establish a successor private equity fund, jointly managed by the two parties, that will target China’s tech sector.

Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.

Founded in 1969, Hong Kong-based Sun Hung Kai & Co is an investment company listed in the Hong Kong Stock Exchange. Its founder, Fung King-hey, is also the co-founder of Sun Hung Kai Properties. It invests mainly in finance, fintech, health insurance, media and technology sectors. The company has about HKD 43bn in assets and is the main shareholder of UA Finance and Everbright Sun Hung Kai.

This private Portuguese healthcare group was established in 2000 and based in Lisbon. It made its first investment in a startup in 2019 when it led the €600,000 seed round of medtech UpHill, a SaaS for healthcare professionals to keep up-to-speed on the latest clinical treatments and protocols using AI. The group’s Hospital da Luz was one of UpHill’s first customers.    

Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.

Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.

Yingke PE was founded in 2010 and is headquartered in Shanghai. By the end of 2020, it had managed assets worth nearly RMB 50bn. In May 2021, it closed the RMB 10bn Yingke Science & Technology Innovation Industrial Fund. Over 90% of its funds come from financial institutions, state-owned enterprises and listed companies. Yingke PE has invested in more than 200 companies, focusing on biopharmaceuticals, core technology and upgraded consumption. Since its founding, the company has exited 53 projects, with an internal rate of return up to 54%.

Originally formed in 2014 as NSI Ventures, Openspace Ventures makes investments in technology companies based in Southeast Asia. Led by Shane Chesson and Hian Goh, Openspace Ventures used to be a part of Northstar Group, a private equity firm primarily invested in the financial services, retail, energy and telecom sectors. In 2018, Chesson and Goh took NSI Ventures independent and rebranded it as Openspace Ventures. They still maintain links with Northstar, with Northstar managing partner Patrick Goh becoming senior advisor to Openspace.

Silicon Valley-based Tyche Partners was founded in 2015 to invest in hardtech sectors such as SpaceTech, IoT devices, cloud and enterprise infrastructure. Managing partner Weijie Yun is a computer science engineer and veteran entrepreneur as founder and CEO of Telegent Systems, AIP Networks and SiTek.The VC firm currently has 18 startups in its portfolio, including being lead investor for the $12m Series A round of Vence in May 2021. Vence is a California-based producer of virtual fencing wearables for livestock management.

Founded in 2019, Country Garden Venture Capital is the corporate venturing arm of Chinese real estate developer Country Garden. With its parent company as the cornerstone investor, it is focused on certain sectors of the supply chain, namely, technology, healthcare and consumption. As of March 2021, Country Garden Venture Capital has invested around RMB 10bn in over 50 companies with an average return above 80%. Among them, 15 have achieved unicorn status ($1bn in valuation), while four have successfully gone public.

Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO.  Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications,  developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley 

González-Montejano is the Spanish CEO and co-founder of AI-enhanced insurtech SingularCover, where he has worked since 2018. Prior to this, he briefly worked as CMO at the US-based Center for Cross-Cultural Studies, an exchange program, and at Madrid-based automotive marketplace startup Autingo. He previously spent five years as Senior Vice-President for Southern Europe of Affinion, a global leader in loyalty and engagement solutions and a provider of insurance to large multinationals. Before that, he had spent almost two decades working in the US, the UK, Spain and Southern Europe in a range of executive posts in large multinationals, incuding Citigroup and BNP Paribas. He holds an MBA in Finance from Carroll School of Management, Boston College, and a Business Administration degree from the University of Massachusetts Amherst, as well as a professional qualification as a licensed insurance broker in Spain. González-Montejano volunteers frequently for organizations helping the elderly. 

Francis Obirikorang completed a bachelor’s degree in materials engineering in 2006 at Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi, Ghana.In 2008, Obirikorang started work as a technical writer at Esoko, a Ghanaian digital development agency in Accra, where he met web developer Michael Ocansey. Obirikorang left Esoko in 2010 and became lead technical writer for Corenett, a transactions processing management company. In 2013, he worked at digital advertising agency TXT Ghana as a business analyst until 2015.In January 2015, Obirikorang and Ocansey established their first startup Swappaholics Holdings in the British Virgin Islands. In 2016, the two friends also co-founded AgroCenta (Holdings) Limited in Mauritius with Obirikorang as CEO and Ocansey as CTO. Ocansey left the Swappaholics in 2016 to focus on building AgroCenta.Obirikorang still runs both companies as CEO and joined the global entrepreneur community Startup Grind in 2016 as chapter director of Kumasi, Ghana’s second-largest city.

Established in San Francisco in 1998, global VC firm e.ventures now has offices and teams in the US, Brazil, Germany, China and Japan. The company invests from seed stage to later stages in sums ranging from US$500,000 to US$30m. It has invested in over 275 companies to date, as lead investor in 70, and has managed 42 exits, including Groupon and Farfetch. Recent investments include cloud-based contract management company Icertis's US$115m Series E round and workforce app Staffbase's Series C round. The VC has six investment funds, totaling US$1.1bn, including a US$125m European-dedicated fund established in June 2019.

Sorry, we couldn’t find any matches for“Target Global”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.